{
    "data": [
        {
            "id": "6903c454ecb8a7000145c077",
            "title": "Behind the Scenes of Docusign&#39;s Latest Options Trends",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">Deep-pocketed investors have adopted a bullish approach towards Docusign (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/DOCU\" target=\"_blank\">DOCU</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in DOCU usually suggests something big is about to happen.</p><!--/$--><!--$--><p class=\"block core-block\">We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Docusign. This level of activity is out of the ordinary.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The general mood among these heavyweight investors is divided, with 62% leaning bullish and 25% bearish. Among these notable options, 2 are puts, totaling $63,713, and 6 are calls, amounting to $264,490.</p><!--/$--><!--$--><h3 class=\"block core-block\">Predicted Price Range</h3><!--/$--><!--$--><p class=\"block core-block\">Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $70.0 to $85.0 for Docusign over the recent three months. </p><!--/$--><!--$--><div class=\"sc-ewfYpr ctXQJP\"></div><!--/$--><!--$--><h3 class=\"block core-block\">Volume &amp; Open Interest Trends</h3><!--/$--><!--$--><p class=\"block core-block\">In today's trading context, the average open interest for options of Docusign stands at 725.25, with a total volume reaching 1,006.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Docusign, situated within the strike price corridor from $70.0 to $85.0, throughout the last 30 days.</p><!--/$--><!--$--><h3 class=\"block core-block\">Docusign Option Volume And Open Interest Over Last 30 Days</h3><!--/$--><!--$--><div class=\"sc-feVKPA LhjAx core-image flex items-center justify-center\"><span style=\"background:none;border:0;box-sizing:border-box;display:inline-block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:relative;max-width:100%\"><span style=\"background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;padding:0;width:initial;max-width:100%\"><img alt=\"\" aria-hidden=\"true\" src=\"data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iMTUwMCIgaGVpZ2h0PSI4MDAiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyIgdmVyc2lvbj0iMS4xIi8+\" style=\"background:none;border:0;display:block;height:initial;margin:0;max-width:100%;opacity:1;padding:0;width:initial\"/></span><img alt=\"\" decoding=\"async\" loading=\"lazy\" src=\"data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/><noscript><img alt=\"\" decoding=\"async\" fetchpriority=\"low\" loading=\"lazy\" sizes=\"(max-width: 800px) 1500px, (min-width: 800px) 1500px\" src=\"https://www.benzinga.com/files/images/story/2025/1761854549_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=3840\" srcset=\"https://www.benzinga.com/files/images/story/2025/1761854549_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1920 1x, https://www.benzinga.com/files/images/story/2025/1761854549_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=3840 2x\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/></noscript></span></div><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><h3 class=\"block core-block\">Largest Options Trades Observed:</h3><!--/$--><!--$--><!--/$--><!--$--><h3 class=\"block core-block\">About Docusign</h3><!--/$--><!--$--><p class=\"block core-block\">Docusign offers Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its initial public offering in 2018.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Having examined the options trading patterns of Docusign, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p><!--/$--><!--$--><h3 class=\"block core-block\">Docusign's Current Market Status</h3><!--/$--><!--$--><ul class=\"block core-block\">\n<li>Trading volume stands at 3,876,848, with DOCU's price up by 3.83%, positioned at $71.62.</li>\n<li>RSI indicators show the stock to be may be approaching overbought.</li>\n<li>Earnings announcement expected in 35 days.</li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h3 class=\"block core-block\">What The Experts Say On Docusign</h3><!--/$--><!--$--><p class=\"block core-block\">A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $124.0.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Turn $1000 into $1270 in just 20 days?</strong></p><!--/$--><!--$--><p class=\"block core-block\">20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href=\"https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage\" target=\"_blank\"><strong>Click here for access</strong></a>.\n* In a cautious move, an analyst from JMP Securities downgraded its rating to Market Outperform, setting a price target of $124. </p><!--/$--><!--$--><p class=\"block core-block\">Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Docusign options trades with real-time alerts from <a href=\"https://www.benzinga.com/pro/\" target=\"_blank\">Benzinga Pro</a>.</p><!--/$--></div></div>",
            "image": "",
            "link": "https://www.benzinga.com/insights/options/25/10/48543200/behind-the-scenes-of-docusigns-latest-options-trends",
            "pub_date": "2025-10-31 04:02:32",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6903c4d8ecb8a7000145c132",
            "title": "Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here&#39;s How ETFs Stand To Gain",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><a href=\"https://www.benzinga.com/etfs\" target=\"_blank\">Healthcare ETFs</a> are quietly feasting on the gains from Wall Street’s latest obsession – the $150 billion obesity-drug boom. As <strong>Eli Lilly And Co</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/LLY\" target=\"_blank\">LLY</a>), <strong>Novo Nordisk A/S</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/NVO\" target=\"_blank\">NVO</a>), and <strong>Pfizer Inc</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/PFE\" target=\"_blank\">PFE</a>) jostle for dominance in the fast-growing GLP-1 market, investors pile into ETFs that offer diversified and far less calorie-dense ways to play the trend.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><em>Elli Lily stock is up almost 5% on Thursday. <a href=\"https://www.benzinga.com/quote/LLY\" target=\"_blank\">Track its prices, live</a>.</em></li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The <strong>Health Care Select Sector SPDR Fund</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/XLV\" target=\"_blank\">XLV</a>) is one of the largest and most liquid U.S. healthcare ETFs, with Eli Lilly as its top holding. Lilly alone constitutes over 12% of the fund, which also includes heavyweights like <strong>Johnson &amp; Johnson </strong>(NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/JNJ\" target=\"_blank\">JNJ</a>), <strong>AbbVie Inc</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/ABBV\" target=\"_blank\">ABBV</a>) and <strong>Merck &amp; Co Inc</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/MRK\" target=\"_blank\">MRK</a>), making XLV a go-to for investors seeking broad yet concentrated exposure to the pharma surge.</p><!--/$--><!--$--><p class=\"block core-block\">The <strong>iShares U.S. Pharmaceuticals ETF</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/IHE\" target=\"_blank\">IHE</a>) offers an even more targeted play, with roughly 20 of America's biggest drugmakers, including Lilly and Pfizer. The fund has gained traction this week as investors digest Lilly's blowout earnings and Novo's <a href=\"https://www.benzinga.com/m-a/25/10/48533502/pfizer-blasts-novo-nordisks-9-billion-counteroffer-for-metsera-as-reckless\" target=\"_blank\">audacious takeover bid for Metsera</a>. On Thursday, the fund was up almost 2%. </p><!--/$--><!--$--><p class=\"block core-block\">The <strong>VanEck Pharmaceutical ETF</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/PPH\" target=\"_blank\">PPH</a>) adds a global flavor to the mix, combining U.S. and European pharma names like Novo Nordisk alongside Lilly and Pfizer to give it a front-row seat to the obesity drug arms race.</p><!--/$--><!--$--><div class=\"sc-fzzUx jSgJNL\"></div><!--/$--><!--$--><p class=\"block core-block\">For investors who prefer the theme-first approach, the <strong>Roundhill GLP-1 &amp; Weight Loss ETF </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/OZEM\" target=\"_blank\">OZEM</a>) has emerged as a pure-play bet on the anti-obesity revolution. The fund focuses exclusively on companies leading the charge of this megatrend in weight loss and diabetes treatment, from established GLP-1 producers to emerging biotech developers.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Eli Lilly Leads, Rivals Fight </h2><!--/$--><!--$--><p class=\"block core-block\">Setting the tone for the sector were third-quarter results from Eli Lilly, whose adjusted earnings of $7.02 per share topped estimates and raised its full-year profit forecast to as high as $23.70. </p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">But across the Atlantic, Novo Nordisk is making headlines of its own, launching a $6.5 billion counterbid for U.S. biotech Metsera, edging out Pfizer’s earlier deal. Metsera is developing a few experimental weight-loss treatments, including a shot that can be taken less frequently than Novo Nordisk's Wegov, making the deal attractive to the giant.</p><!--/$--><!--$--><p class=\"block core-block\">Pfizer, which is still regaining its footing after the pandemic vaccine windfall faded, called Novo’s move “reckless” and anticompetitive, but the fight underscores how high the stakes have become in the GLP-1 gold rush.</p><!--/$--><!--$--><p class=\"block core-block\">With Lilly tightening its lead, Novo flexing its balance sheet, and Pfizer trying to claw back relevance, the obesity-drug race is reshaping the global pharma landscape-and ETFs are emerging as the easiest way to stay invested in the frenzy. </p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48543376\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/etfs/sector-etfs/25/10/48535168/nvidias-5-trillion-milestone-turns-these-ai-etfs-into-hot-trades\" target=\"_blank\">Nvidia’s $5 Trillion Milestone Turns These AI ETFs Into Hot Trades</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo by shisu_ka via Shutterstock</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/Diet-And-Dieting--Beauty-Slim-Female-Bod.jpeg",
            "link": "https://www.benzinga.com/etfs/sector-etfs/25/10/48543376/eli-lilly-extends-lead-in-150b-obesity-drug-race-as-novo-pfizer-clash-heres-how-etfs-stand-to-gain",
            "pub_date": "2025-10-31 04:04:44",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6903bac6ecb8a7000145b9bb",
            "title": "Chipotle CEO Says Gen Z Is Eating Out Less — But He&#39;s Not Lowering Prices",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>Chipotle Mexican Grill Inc</strong>'s (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/CMG\" target=\"_blank\">CMG</a>) cult following may not be recession-proof after all. CEO <strong>Scott Bowright</strong> admitted during Chipotle’s <a href=\"https://www.benzinga.com/quote/CMG/earnings\" target=\"_blank\">third quarter earnings</a> call that younger and lower-income consumers are pulling back — but he's drawing a firm line: no discounts. </p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Track CMG stock <a href=\"https://www.benzinga.com/quote/cmg\" target=\"_blank\">here</a>.</strong></li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">\"We're losing lower-income and younger consumers to grocery,\" Bowright said, underscoring that even the most beloved burrito brand isn't immune to tightening wallets. \"We're not going to chase short-term traffic with deals. That's not who we are.\"</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Read Also: <a href=\"https://www.benzinga.com/news/restaurants/25/09/47629841/cava-chipotle-trade-like-bargains-but-wall-street-hasnt-caught-up-yet\" target=\"_blank\">Cava, Chipotle Trade Like Bargains—But Wall Street Hasn’t Caught Up Yet</a></strong></p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Refusing To Play The Discount Game</h2><!--/$--><!--$--><p class=\"block core-block\">While competitors are testing value menus and limited-time offers, Chipotle is taking the opposite route — betting that premium positioning will outlast consumer fatigue. It's a risky strategy in a market where affordability has become a brand identity of its own.</p><!--/$--><!--$--><div class=\"sc-eQzVdq kfhAgV\"></div><!--/$--><!--$--><p class=\"block core-block\">Chains like <strong>Sweetgreen Inc </strong>(NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/SG\" target=\"_blank\">SG</a>) and <strong>CAVA Group Inc</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/CAVA\" target=\"_blank\">CAVA</a>) are also feeling the pinch from shifting Gen Z habits. Both have leaned into digital loyalty programs and smaller portions to hold margins, while Chipotle's refusal to budge on pricing could test the limits of its pricing power.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Fast Casual Faces Its First Real Stress Test</h2><!--/$--><!--$--><p class=\"block core-block\">The broader fast-casual space — long viewed as insulated from QSR (Quick Service Restaurant) price wars — is facing a reality check. Grocery prices are easing, making at-home eating comparatively cheaper for younger diners. Add in high student debt and slowing wage growth, and traffic could stay pressured through 2026.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">Still, Bowright's defiance might be the right long game. By maintaining premium perception and avoiding discount dilution, Chipotle could preserve brand equity — even if near-term traffic dips. Investors may prefer a short-term volume slowdown to a long-term erosion of pricing power.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Investor Takeaway</h2><!--/$--><!--$--><p class=\"block core-block\">Chipotle's message is clear: it's not joining the race to the bottom. For investors, that sets up a fascinating divergence across the fast-casual sector — with Cava and Sweetgreen experimenting to retain traffic while Chipotle doubles down on brand integrity.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">If Bowright's bet pays off, it could prove that in a high-inflation, low-loyalty era, pricing power — not promotions — is the real moat.</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48541615\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><a href=\"https://www.benzinga.com/trading-ideas/movers/25/10/48467609/paypal-ceo-says-gen-z-is-ditching-credit-cards-bnpl\" target=\"_blank\"><strong>PayPal CEO Says Gen Z Is Ditching Credit Cards — And He’s Cashing In</strong></a></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Image created using artificial intelligence via DALL-E.</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/chipotle-dall-e.png",
            "link": "https://www.benzinga.com/news/restaurants/25/10/48541615/chipotle-ceo-says-gen-z-is-eating-out-less-but-hes-not-lowering-prices",
            "pub_date": "2025-10-31 03:21:55",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6903c23cecb8a7000145becb",
            "title": "Trump&#39;s White House Build Gets The South Park Treatment In Halloween Episode: Here&#39;s How To Watch",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><span style=\"box-sizing:border-box;margin:0px;padding:0px\">In 2025, the hit animated comedy \"South Park\" has ramped up its<a href=\"https://www.benzinga.com/news/entertainment/25/08/46979368/south-park-takes-on-kristi-noem-shooting-dogs-jd-vance-as-trump-assistant-vp-says-ive-finally-made-it\" rel=\"noopener\" target=\"_blank\"> anti-Trump storylines</a> with episodes featuring President <strong>Donald Trump, JD Vance, Kristi Noem, Mark Zuckerberg, </strong>and <strong>Tim Cook,</strong> all used to make fun of the current White House administration.</span></p><!--/$--><!--$--><p class=\"block core-block\">The newest episode <span style=\"box-sizing:border-box;margin:0px;padding:0px\">focuses on the demolition of the East Wing of the White House and comes as <strong>Paramount Skydance </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/PSKY\" target=\"_blank\">PSKY</a>) receives</span> the <a href=\"https://www.benzinga.com/news/politics/25/10/48417988/trump-vs-netflix-apple-white-house-warns-warner-bros-should-think-really-hard-about-bidders\" target=\"_blank\">Trump administration's support </a>for a potential merger with<strong> Warner Bros. Discovery </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/WBD\" target=\"_blank\">WBD</a>).</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">New \"South Park\" Episode</h2><!--/$--><!--$--><p class=\"block core-block\">Viewership for \"South Park\" episodes featuring Trump <a href=\"https://www.benzinga.com/news/entertainment/25/07/46769277/trump-jokes-on-south-park-help-lift-viewership-by-68\" target=\"_blank\">have seen an increase</a> in 2025 with the show poking fun at various policies and parts o the administration.</p><!--/$--><!--$--><p class=\"block core-block\">A new Halloween episode titled \"The Woman in the Hat\" will premiere on Friday, Oct. 31, on Comedy Central, deviating from its traditional Wednesday air date, as <a href=\"https://variety.com/2025/tv/news/south-park-white-house-demolition-episode-halloween-1236564058/\" target=\"_blank\">reported </a>by Variety. The episode premieres at 10 p.m. ET.</p><!--/$--><!--$--><p class=\"block core-block\">For those without Comedy Central, the episode will be released on streaming platform Paramount+ on Saturday.</p><!--/$--><!--$--><div class=\"sc-SfCGz ciVbir\"></div><!--/$--><!--$--><p class=\"block core-block\">The episode is the second of the new Season 28. It will feature a plot involving the demolition of the White House’s east wing and the construction of a new ballroom, mirroring the current state of the Trump administration.</p><!--/$--><!--$--><p class=\"block core-block\">Friday's episode will feature Noem and <strong>Stephen Miller,</strong> two members of the White House administration, along with Trump and Satan, who plays his lover in seasons 27 and 28.</p><!--/$--><!--$--><p class=\"block core-block\">The episode features a \"disruptive spirit from the east wing\" that could end up haunting members of the White House administration.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">Future episodes in Season 28 are planned for Wednesdays, with dates of Nov. 12, Nov. 26, and Dec. 10. The show has switched to an every-other-week Wednesday release, but has changed this several times.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Read Also: <a href=\"https://www.benzinga.com/news/politics/25/10/48450567/trumps-ai-images-on-social-media-tacky-disturbing-unpresidential-majority-of-voters-disapprove\" target=\"_blank\">Trump’s AI Images On Social Media ‘Tacky,’ ‘Disturbing’ &amp; ‘Unpresidential’: Majority Of Voters Disapprove</a></strong></p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Trump Administration Supports Paramount, Will Things Changed?</h2><!--/$--><!--$--><p class=\"block core-block\">Paramount Skydance completed its merger with approval from the Trump administration, an event that followed Paramount unit CBS settling a lawsuit with the president.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The Trump administration showed support to Paramount Skydance in recent months, even with the animated show poking fun at the president.</p><!--/$--><!--$--><p class=\"block core-block\">With a potential bidding war brewing for Warner Bros. Discovery, the Trump administration even cautioned bidders that weren't named Paramount Skydance.</p><!--/$--><!--$--><p class=\"block core-block\">“Who owns Warner Bros. Discovery is every important to the administration,” a senior Trump administration official <a href=\"https://nypost.com/2025/10/23/media/trump-admin-favors-paramount-skydance-in-race-to-buy-warner-bros-discovery-sources/\" rel=\"noreferrer noopener\" target=\"_blank\">told</a> the New York Post. “The Warner board needs to think very seriously not just on the price competition but which player in the suitor pool has been successful getting a deal done.”</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The senior administration official went on to say that this \"points to the Ellisons,\" a reference to Paramount Skydance CEO <strong>David Ellison</strong> and his father, Oracle co-founder <strong>Larry Ellison,</strong> a longtime ally of Trump and one of the top owners of the media company.</p><!--/$--><!--$--><p class=\"block core-block\">Paramount Skydance has made recent changes to its CBS News division in a push to end what it calls left-wing bias. The company also announced it would end <strong>Stephen Colbert's</strong> late-night show, a move that pleased the president.</p><!--/$--><!--$--><p class=\"block core-block\"><span style=\"box-sizing:border-box;margin:0px;padding:0px\">The media company signed a five-year $1.5 billion deal with \"South Park\" creators<strong> Matt Stone </strong>and <strong>Trey Parker,</strong> and so far has given them the ability to keep poking fun at the president, but the question could be how long until the president asks for this to stop.</span></p><!--/$--><!--$--><p class=\"block core-block\">Following the season 27 premiere of \"South Park,\" the White House <a href=\"https://www.benzinga.com/news/politics/25/07/46615709/south-park-goes-anti-trump-with-satan-jesus-president-white-house-says-show-hasnt-been-relevant-for-20-years\" target=\"_blank\">offered a response </a>to the depiction of Trump.</p><!--/$--><!--$--><p class=\"block core-block\">“This show hasn’t been relevant for over 20 years and is hanging on by a thread with uninspired ideas in a desperate attempt for attention,” White House spokesperson <strong>Taylor Rogers</strong> told Variety.</p><!--/$--><!--$--><p class=\"block core-block\">Rogers said “the Left” has gone after South Park’s offensive content for years but is now praising the animated comedy.</p><!--/$--><!--$--><p class=\"block core-block\">“Just like the creators of ‘South Park,’ the Left has no authentic or original content, which is why their popularity continues to hit record lows.”</p><!--/$--><!--$--><p class=\"block core-block\">The new episode poking fun at the demolition of the White House could go too far and touch a nerve with the president.</p><!--/$--><!--$--><p class=\"block core-block\">A recent YouGov poll found that 53% of voters polled said <a href=\"https://www.benzinga.com/news/politics/25/10/48422447/trumps-approval-rating-firm-as-shutdown-drags-on-and-east-wing-demolition-sparks-debate\" target=\"_blank\">they were against </a>Trump's decision to demolish the East Wing, with only 28% saying they were in favor of the move.</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48542798\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/news/entertainment/25/10/48449919/paramount-vs-comcast-sheridan-walks-what-happens-to-yellowstone-now\" target=\"_blank\">Paramount Vs. Comcast: Sheridan Walks — What Happens To ‘Yellowstone’ Now?</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Image created using artificial intelligence via DALL-E.</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/white-house-dall-e.png",
            "link": "https://www.benzinga.com/news/politics/25/10/48542798/trumps-white-house-build-gets-the-south-park-treatment-in-halloween-episode-heres-how-to-watch",
            "pub_date": "2025-10-31 03:53:35",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6903c09fecb8a7000145bd88",
            "title": "Trump And Xi Found A Trade Truce—But Wall Street Wanted More",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">Markets barely flinched after President <strong>Donald Trump</strong>'s high-profile meeting with Chinese leader <strong>Xi Jinping</strong> in South Korea, as investors found little substance in the much-hyped U.S.-China trade truce that largely echoed prior leaks <a href=\"https://www.benzinga.com/news/politics/25/10/48519309/trump-concludes-amazing-meeting-with-xi-jinping-teases-pretty-soon-trade-deal\" target=\"_blank\">and delivered few surprises.</a></p><!--/$--><!--$--><p class=\"block core-block\">A cocktail of mixed earnings, hawkish remarks from Fed Chair <strong>Jerome Powell</strong>, and a less-than-exceptional Trump-Xi meeting dragged tech and global markets lower on Thursday. </p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The <strong>Invesco QQQ Trust </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/QQQ\" target=\"_blank\">QQQ</a>) dropped 1%, led by a sharp 10% plunge in <strong>Meta Platforms Inc. </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/META\" target=\"_blank\">META</a>) after the company revealed a surprise surge in AI-related capital spending.</p><!--/$--><!--$--><p class=\"block core-block\">China-exposed stocks weren't spared either. The <strong>Invesco China Technology ETF </strong>(NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/CQQQ\" target=\"_blank\">CQQQ</a>) fell 1.9%, while the<strong> iShares China Large-Cap ETF </strong>(NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/FXI\" target=\"_blank\">FXI</a>) slipped 1.7%, as investors questioned the real impact of the U.S.-China trade truce.</p><!--/$--><!--$--><p class=\"block core-block\">Chinese tech ADRs trading in New York were all in the red, with <strong>Alibaba Group Holding Ltd.</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/BABA\" target=\"_blank\">BABA</a>) falling 2.77%, <strong>PDD Holdings Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/PDD\" target=\"_blank\">PDD</a>) down 1.34%, <strong>JD.com Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/JD\" target=\"_blank\">JD</a>) sliding 2.43%, <strong>Baidu Inc.</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/BIDU\" target=\"_blank\">BIDU</a>) losing 3.71% and <strong>Li Auto Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/LI\" target=\"_blank\">LI</a>) dropping 2%.</p><!--/$--><!--$--><div class=\"sc-fzzUx jSgJNL\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Trump Gave China Tariff Relief—Investors Are Wondering What He Got Back</h2><!--/$--><!--$--><p class=\"block core-block\">Despite headline-worthy gestures, including mutual tariff reductions and suspended rare earth controls, investors viewed the Trump-Xi outcome as symbolic rather than strategic.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Michael Hirson</strong>, analyst at 22V Research, said the deal reflected a \"major climbdown\" by Trump. The president suspended the so-called \"50% rule\" on Chinese exports and agreed to slash fentanyl-related tariffs by half.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">China, in return, paused its export controls on rare earths and promised to buy more U.S. agricultural goods like soybeans and sorghum.</p><!--/$--><!--$--><p class=\"block core-block\">While the tone suggested de-escalation, the markets read between the lines: the two leaders avoided discussing semiconductors, Taiwan and TikTok ownership—hot-button issues that could reignite friction in months.</p><!--/$--><!--$--><p class=\"block core-block\">\"Today's agreement appears to be a ‘win' for both sides,\" said <strong>Roman Ziruk</strong>, senior analyst at Ebury, \"but a flare-up in tensions down the road is not out of the question.\"</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Nvidia And Chips: The Critical Issue Was Missing</h2><!--/$--><!--$--><p class=\"block core-block\">Notably absent from the Trump-Xi agenda was the elephant in the room: <strong>Nvidia Corp</strong>. (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/NVDA\" target=\"_blank\">NVDA</a>) and the thorny issue of advanced chip sales to China. </p><!--/$--><!--$--><p class=\"block core-block\">Trump avoided direct mention of the B30A chip—designed specifically for the Chinese market—but his openness to allowing sales has already sparked backlash.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The tech war is not cooling, even if tariffs are. Beijing's dependence on U.S. chips remains acute, while Washington faces pressure from domestic hawks to tighten controls. </p><!--/$--><!--$--><p class=\"block core-block\"><strong>Louise Loo</strong>, head of Asia economics at Oxford Economics, warned the détente is \"fragile\" and “highly sensitive to perceived escalations.”</p><!--/$--><!--$--><p class=\"block core-block\">\"Recent history suggests the risk of policy miscalculation and misunderstanding is high,\" she said, adding that \"China's leverage in rare earths and critical minerals will continue to surface episodically, effectively capping any escalation in bilateral tensions.\"</p><!--/$--><!--$--><p class=\"block core-block\">She warned that \"the four Ts\"—Taiwan, transshipments, TikTok and technology—remain unresolved, making the peace more of a pause than a pivot.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Short-Term Stability, Long-Term Uncertainty</h2><!--/$--><!--$--><p class=\"block core-block\">While both sides may enjoy a temporary reprieve, structural tensions remain unresolved. Trump is expected to visit China in April 2026, but his delay from early Q1 signals there may not be much more on the table in the short run.</p><!--/$--><!--$--><p class=\"block core-block\">\"The worst of the trade war appears to be behind us,\" said Ziruk, \"but the relationship will need to be managed carefully.\"</p><!--/$--><!--$--><p class=\"block core-block\">Markets seem to agree: the calm may be temporary, and investors aren't rushing to price in peace just yet.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Now Read</strong>:</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><a href=\"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/10/48531059/google-alphabet-stock-rally-earnings-analysts-outlook-analysis-price-target\" target=\"_blank\"><strong>Google’s Hottest Stock Rally In Over 20 Years Is Far From Over, Analysts Say</strong></a></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Image: Shutterstock</em></p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48542492\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/Trump--Xi-meet-at-APEC.jpeg",
            "link": "https://www.benzinga.com/news/politics/25/10/48542492/trump-xi-meeting-us-china-trade-deal-war-tariffs-fentanyl-nvidia-tech-taiwan-semiconductors-exports-rare-earths",
            "pub_date": "2025-10-31 03:46:43",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}